Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-09-19

Clinical Trial Update: Effects of FES-Rowing in Neurological Disorders (FES-ROW) [NA]

View source ↗

Summary

The clinical trial evaluating FES-Rowing for spinal cord injury has been withdrawn. No results or ongoing activity are reported for this study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FES-Rowing

Snippet

Sponsor: UGECAM Rhône-Alpes | Conditions: Spinal Cord Injuries | NA | Status: WITHDRAWN